Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03557359 |
Title | Nivolumab for Recurrent or Progressive IDH Mutant Gliomas |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Columbia University |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Miami Cancer Center | Miami | Florida | 33176 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Columbia University Medical Center | New York | New York | 10032 | United States | Details | |
Weill Cornell Medical College | New York | New York | 10065 | United States | Details |